177 related articles for article (PubMed ID: 8039476)
1. Gabapentin: discussion.
Fromm GH
Epilepsia; 1994; 35 Suppl 5():S77-80. PubMed ID: 8039476
[TBL] [Abstract][Full Text] [Related]
2. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
Leiderman DB
Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475
[TBL] [Abstract][Full Text] [Related]
3. Monotherapy trials with gabapentin for partial epilepsy.
Beydoun A
Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
[TBL] [Abstract][Full Text] [Related]
5. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Hosford DA; Wang Y
Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
[TBL] [Abstract][Full Text] [Related]
6. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures].
Pierce MW; Shokry A
Praxis (Bern 1994); 1997 Sep; 86(37):1430-1. PubMed ID: 9381042
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin.
Morris GL
Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report.
Gaida-Hommernick B; Rieck K; Runge U
Epilepsia; 2001 Jun; 42(6):793-5. PubMed ID: 11422339
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant activity of PNU-151774E in the amygdala kindled model of complex partial seizures.
Maj R; Fariello RG; Pevarello P; Varasi M; McArthur RA; Salvati P
Epilepsia; 1999 Nov; 40(11):1523-8. PubMed ID: 10565578
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drugs in development: prospects for the near future.
Leppik IE
Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
[TBL] [Abstract][Full Text] [Related]
13. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
[TBL] [Abstract][Full Text] [Related]
14. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
Bruni J
Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
[TBL] [Abstract][Full Text] [Related]
15. Gabapentin associated with aggressive behavior in pediatric patients with seizures.
Tallian KB; Nahata MC; Lo W; Tsao CY
Epilepsia; 1996 May; 37(5):501-2. PubMed ID: 8617181
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
[TBL] [Abstract][Full Text] [Related]
17. Gabapentin in refractory partial epilepsy--a trial in India.
Dixit SN; Jain S; Padma MV; Maheshwari MC
Acta Neurol Scand; 1996; 93(2-3):85-7. PubMed ID: 8741123
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
Handforth A; Treiman DM
Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
Leach JP; Girvan J; Paul A; Brodie MJ
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
[TBL] [Abstract][Full Text] [Related]
20. Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial.
DeToledo JC; Ramsay RE; Lowe MR; Greiner M; Garofalo EA
Ther Drug Monit; 2000 Dec; 22(6):753-6. PubMed ID: 11128246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
